The Food and Drug Administration today authorized emergency use of the experimental antiviral drug remdesivir for treating COVID-19 in the wake of encouraging results from a federally backed clinical trial.
The Food and Drug Administration today authorized emergency use of the experimental antiviral drug remdesivir for treating COVID-19 in the wake of encouraging results from a federally backed clinical trial.